Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Brii Biosciences Ltd
2137Current price
1.08 HKD
-0.1 HKD (-8.47%)
Last closed
1.08 HKD
Company
www.briibio.com
ISIN
KYG1645A1094
Sector
Healthcare
Industry
Biotechnology
Exchange
Hong Kong Stock Exchange
Capitalization
775 589 491 HKD
Yield for 12 month
-59.40 %
1Y
3Y
5Y
10Y
15Y
2137
Brii Biosciences Limited engages in the research and development of therapies for the treatment of infectious and central nervous system diseases in China and the United States. The company develops BRII-179, BRII-835, and BRII-877, which are in Phase 2 the development of a functional cure for HBV for Hepatitis B; BRII-179, a recombinant protein-based HBV immunotherapeutic candidate that is in Phase 2; and BRII-732 that is in Phase 1 clinical trial and BRII-753, which is in preclinical stage for the treatment of HIV. It develops BRII-296 for the treatment of PPD/MDD, anxiety, and other depressive disorders; BRII-297 for treatment of various depressive disorders; BRII-693 for the treatment of multi-drug resistant/extensive drug resistant (MDR/XDR) gram-negative infections; and BRII-658 for oral treatment for patients with chronic NTM lung disease. Brii Biosciences Limited was incorporated in 2017 and is headquartered in Beijing, China. Address: Building 7, International Science Park, Beijing, China, 100192
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
7.78 HKDP/E ratio
–Dividend Yield
–Current Year
+665 903 HKD
Last Year
+55 717 803 HKD
Current Quarter
+665 903 HKD
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures 2137
1 year
3 years
5 years
10 years
EBITDA
-488 953 919 HKD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-10.12 %
PEG Ratio
–
Return On Equity TTM
-9.18 %
Wall Street Target Price
7.78 HKD
Revenue TTM
38 416 921 HKD
Book Value
3.92 HKD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-44.7 %
Dividend Yield
–
Gross Profit TTM
147 335 600 HKD
Earnings per share
–
Diluted Eps TTM
–
Most Recent Quarter
II 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 2137
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 2137
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 2137
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
20.1887
Enterprise Value EBITDA
0.226
Price Book MRQ
0.2525
Financials 2137
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 2137
For 52 weeks
0.85 HKD
3.5 HKD
50 Day MA
1.08 HKD
Shares Short Prior Month
–
200 Day MA
1.18 HKD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart